Commerce Bank Astrazeneca PLC Transaction History

Commerce Bank

$17.7 Billion
Q3 2025

A detailed history of Commerce Bank transactions in Astrazeneca PLC stock. As of the latest transaction made, Commerce Bank holds 24,582 shares of AZN stock, worth $2.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,582

Previous 19,727 24.61%

Holding current value

$2.2 Million

Previous $1.38 Million 36.79%

% of portfolio

0.01%

Previous 0.01%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$68.72 - $82.11 $333,635 - $398,644	4,855 Added 24.61%	24,582 $1.89 Million
Q2 2025 Aug 07, 2025	BUY	$64.87 - $75.0 $6,681 - $7,725	103 Added 0.52%	19,727 $1.38 Million
Q1 2025 May 08, 2025	SELL	$65.37 - $77.96 $62,101 - $74,062	-950 Reduced 4.62%	19,624 $1.44 Million
Q4 2024 Feb 13, 2025	BUY	$63.2 - $79.58 $73,375 - $92,392	1,161 Added 5.98%	20,574 $1.35 Million
Q3 2024 Nov 08, 2024	BUY	$76.67 - $87.62 $86,713 - $99,098	1,131 Added 6.19%	19,413 $1.51 Million

Q2 2024 Aug 12, 2024	SELL	$66.81 - $80.83 $37,346 - $45,183	-559 Reduced 2.97%	18,282 $1.43 Million
Q1 2024 May 03, 2024	BUY	$61.03 - $69.57 $13,243 - $15,096	217 Added 1.17%	18,841 $1.28 Million
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $136,281 - $152,554	-2,202 Reduced 10.57%	18,624 $1.25 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $75,615 - $83,602	1,166 Added 5.93%	20,826 $1.41 Million
Q2 2023 Aug 08, 2023	SELL	$69.91 - $75.81 $5,592 - $6,064	-80 Reduced 0.41%	19,660 $1.41 Million
Q1 2023 May 04, 2023	BUY	$63.15 - $71.6 $147,771 - $167,544	2,340 Added 13.45%	19,740 $1.37 Million
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $50,469 - $65,579	-931 Reduced 5.08%	17,400 $1.18 Million
Q3 2022 Nov 04, 2022	BUY	$53.02 - $135.75 $15,216 - $38,960	287 Added 1.59%	18,331 $1.01 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $81,126 - $97,390	-1,369 Reduced 7.05%	18,044 $1.19 Million
Q1 2022 May 09, 2022	BUY	$55.72 - $67.12 $12,369 - $14,900	222 Added 1.16%	19,413 $1.29 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $146,610 - $173,234	-2,714 Reduced 12.39%	19,191 $1.12 Million
Q3 2021 Nov 09, 2021	BUY	$55.56 - $60.79 $629,828 - $689,115	11,336 Added 107.26%	21,905 $1.32 Million
Q2 2021 Aug 09, 2021	SELL	$48.42 - $60.18 $44,691 - $55,546	-923 Reduced 8.03%	10,569 $633,000
Q1 2021 May 05, 2021	BUY	$47.16 - $54.44 $140,819 - $162,557	2,986 Added 35.1%	11,492 $572,000
Q4 2020 Feb 09, 2021	SELL	$48.52 - $58.02 $48,374 - $57,845	-997 Reduced 10.49%	8,506 $425,000
Q3 2020 Nov 06, 2020	BUY	$53.07 - $61.1 $20,007 - $23,034	377 Added 4.13%	9,503 $520,000
Q2 2020 Aug 07, 2020	BUY	$43.1 - $55.31 $19,395 - $24,889	450 Added 5.19%	9,126 $482,000
Q1 2020 May 08, 2020	SELL	$37.79 - $51.33 $3,060 - $4,157	-81 Reduced 0.92%	8,676 $388,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $11,039 - $13,119	260 Added 3.06%	8,757 $437,000
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $48,424 - $54,882	-1,207 Reduced 12.44%	8,497 $379,000
Q2 2019 Aug 07, 2019	SELL	$37.28 - $41.68 $1,864 - $2,084	-50 Reduced 0.51%	9,704 $400,000
Q1 2019 May 08, 2019	BUY	$35.49 - $43.02 $56,358 - $68,315	1,588 Added 19.45%	9,754 $395,000
Q4 2018 Feb 11, 2019	SELL	$36.86 - $41.49 $6,524 - $7,343	-177 Reduced 2.12%	8,166 $310,000
Q3 2018 Nov 02, 2018	SELL	$34.76 - $39.72 $61,942 - $70,781	-1,782 Reduced 17.6%	8,343 $330,000
Q2 2018 Aug 08, 2018	BUY	$34.55 - $37.05 $6,218 - $6,668	180 Added 1.81%	10,125 $356,000
Q1 2018 May 03, 2018	SELL	$32.97 - $36.63 $52,850 - $58,717	-1,603 Reduced 13.88%	9,945 $347,000
Q4 2017 Feb 12, 2018	BUY	$32.09 - $34.78 $27,501 - $29,806	857 Added 8.02%	11,548 $400,000
Q3 2017 Nov 07, 2017	BUY	$28.96 - $34.0 $18,042 - $21,182	623 Added 6.19%	10,691 $365,000
Q3 2017 Nov 07, 2017	BUY	$28.96 - $34.0 $291,569 - $342,312	10,068	10,068 $341,000

Others Institutions Holding AZN

# of Institutions

1,497

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account